Suresh S Ramalingam MD, FACP, FASCO

Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 171

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. ...

Article

First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

by Neal Ready; Matthew D. Hellmann; Mark M. Awad; Gregory A. Otterson; Martin Gutierrez; Justin F. Gainor; Hossein Borghaei; Jacques Jolivet; Leora Horn; Mihaela Mates; Julie Brahmer; Ian Rabinowitz; Pavan S. Reddy; Jason Chesney; James Orcutt; David R. Spigel; Martin Reck; Kenneth John O'Byrne; Luis Paz-Ares; Wenhua Hu; Kim Zerba; Xuemel Li; Brian Lestini; William J. Geese; Joseph D. Szustakowski; George Green; Han Chang; Suresh Ramalingam

2019

Article

PD-1 combination therapy with IL-2 modifies CD8(+) T cell exhaustion program

by Masao Hashimoto; Koichi Araki; Maria A Cardenas; Peng Li; Rohit R Jadhav; Haydn Kissick; William Hudson; Donald J McGuire; Rebecca Obeng; Andreas Wieland; Judong Lee; Daniel T McManus; James L Ross; Sejin Im; Junghwa Lee; Jian-Xin Lin; Bin Hu; Erin E West; Christopher Scharer; Gordon J Freeman; Arlene H Sharpe; Suresh Ramalingam; Alex Pellerin; Volker Teichgraber; William J Greenleaf; Christian Klein; Jorg J Goronzy; Pablo Umana; Warren J Leonard; Kendall A Smith; Rafi Ahmed

2022

Article

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

by Juliann Chmielecki; Tony Mok; Yi-Long Wu; Ji-Youn Han; Myung-Ju Ahn; Suresh Ramalingam; Thomas John; Isamu Okamoto; James Chih-Hsin Yang; Frances A Shepherd; Krishna C Bulusu; Gianluca Laus; Barbara Collins; Carl J Barrett; Ryan J Hartmaier; Vassiliki Papadimitrakopoulou

2023

Article

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227

by Julie R Brahmer; Jong-Seok Lee; Tudor-Eliade Ciuleanu; Reyes Bernabe Caro; Makoto Nishio; Laszlo Urban; Clarisse Audigier-Valette; Lorena Lupinacci; Randeep Sangha; Adam Pluzanski; Jacobus Burgers; Mauricio Mahave; Samreen Ahmed; Adam J Schoenfeld; Luis G Paz-Ares; Martin Reck; Hossein Borghaei; Kenneth J O'Byrne; Ravi G Gupta; Judith Bushong; Li Li; Steven I Blum; Laura J Eccles; Suresh Ramalingam

2023

Article

Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis.

by Chang-Soo Seong; Chunzi Huang; Austin C Boese; Yuning Hou; Junghui Koo; Janna K Mouw; Manali Rupji; Greg Joseph; Richard H Johnston; Henry Claussen; Jeffrey M Switchenko; Madhusmita Behera; Michelle Churchman; Jill M Kolesar; Susanne M Arnold; Katie Kerrigan; Wallace Akerley; Howard Colman; Margaret A Johns; Cletus Arciero; Wei Zhou; Adam Marcus; Suresh Ramalingam; Haian Fu; Melissa Gilbert-Ross

2023

Article

Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer

by William Stokes; Madhusmita Behera; Renjian Jiang; David Gutman; Zhonglu Huang; Abigail Burns; Nikhil Sebastian; Vidula Sukhatme; Michael Lowe; Suresh Ramalingam; Vikas Sukhatme; Drew Moghanaki

2022

Article

mTOR regulates T cell exhaustion and PD-1 targeted immunotherapy response during chronic viral infection

by Satomi Ando; Charles M Perkins; Yamato Sajiki; Chase Chastain; Rajesh M Valanparambil; Andreas Wieland; William Hudson; Masao Hashimoto; Suresh Ramalingam; Gordon J Freeman; Rafi Ahmed; Koichi Araki

2022